Stent-related Symptoms Comparison: Polaris Loop vs Vortek Double-J Stents
Comparison Between Symptoms Related to Polaris Loop Stent Versus Vortek Double J Stent After Uncomplicated Flexible Ureterorenoscopy for Renal Stones
1 other identifier
interventional
68
1 country
1
Brief Summary
Prospective randomized controlled single-blind parallel-group trial in order to compare symptoms related to loop-tail (Polaris Loop) stents versus conventional double J (Vortek) stents after uncomplicated flexible URS.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2018
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 11, 2017
CompletedFirst Posted
Study publicly available on registry
November 17, 2017
CompletedStudy Start
First participant enrolled
January 10, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 13, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
April 17, 2020
CompletedDecember 1, 2020
November 1, 2020
2.1 years
November 11, 2017
November 29, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
USSQ Urinary symptoms scores
Evaluation of significant differences in Urinary symptoms score between the two groups
4 weeks
Secondary Outcomes (3)
USSQ domains scores
4 weeks
USSQ domains scores
2 days
USSQ domains' scores adjusted for baseline
8 weeks
Study Arms (2)
Vortek double-J stent
ACTIVE COMPARATORVortek double-J stent after RIRS.
Polaris Loop stent
ACTIVE COMPARATORPolaris Loop ureteral stent after RIRS.
Interventions
USSQ symptoms questionnaire administration after RIRS
Eligibility Criteria
You may qualify if:
- patients undergoing flexible ureteroscopy and laser lithotripsy for kidney stones \< 2 cm
- given informed consent
- WHO PS 0-2
You may not qualify if:
- significant residual fragments at the end of the procedure
- intraoperative complications (i.e. ureteral damage or ureteral stricture)
- urinary tract infections
- anatomic abnormalities
- chronic diseases or medications potentially influencing pain perception and urinary symptoms (i.e. alpha blockers and antimuscarinics)
- preoperative ureteral stenting.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
AOU Città della Salute e della Scienza
Torino, 10126, Italy
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Andrea Bosio, MD
AOU Città della Salute e della Scienza Torino
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD Urologist, PhD
Study Record Dates
First Submitted
November 11, 2017
First Posted
November 17, 2017
Study Start
January 10, 2018
Primary Completion
February 13, 2020
Study Completion
April 17, 2020
Last Updated
December 1, 2020
Record last verified: 2020-11
Data Sharing
- IPD Sharing
- Will not share